Medicare to limit coverage for Aduhelm, an Alzheimer’s drug with questionable benefits that triggered a jump in premiums

WASHINGTON (AP) — Medicare to limit coverage for Aduhelm, an Alzheimer’s drug with questionable benefits that triggered a jump in premiums.

Copyright © 2022 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up